Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Apellis Pharmaceuticals
Apellis Pharmaceuticals
(APLS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Empaveli
Pegcetacoplan
2021-05-14
2026-2038
Paroxysmal hemoglobinuria
Syfovre
Pegcetacoplan
2023-02-17
2026-2038
Paroxysmal hemoglobinuria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegcetacoplan
wet macular degeneration
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
recurrence
,
kidney diseases
,
iga glomerulonephritis
,
membranous glomerulonephritis
,
lupus nephritis
,
nephritis
,
anemia
,
hemolysis
,
hemolytic anemia autoimmune
,
hemolytic anemia
,
vascular diseases
,
thrombotic microangiopathies
,
geographic atrophy
,
macular degeneration
,
paroxysmal hemoglobinuria
,
hemoglobinuria
,
atrophy
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
,
kidney transplantation
,
neoplasm metastasis
,
chronic kidney failure
,
delayed graft function
Aspartame
cataract
,
inflammation
Nepidermin
urologic neoplasms
,
glioblastoma
,
glioma
,
astrocytoma
,
plasmacytoma
,
neoplasms
,
respiratory tract diseases
,
pleural effusion
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
neoplasms by site
,
malignant pleural effusion
,
pleural diseases
,
pleural neoplasms
,
squamous cell carcinoma of head and neck
,
cutaneous malignant melanoma
,
recurrence
,
stomach neoplasms
,
ovarian neoplasms
,
kidney transplantation
,
graft rejection
,
psychology rejection
,
male breast neoplasms
,
uveal neoplasms
,
uveal melanoma
,
hodgkin disease
,
pancreatic ductal carcinoma
,
serous cystadenocarcinoma
,
adenocarcinoma
,
ovarian epithelial carcinoma
,
carcinosarcoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
endometrial neoplasms
,
merkel cell carcinoma
,
head and neck neoplasms
,
triple negative breast neoplasms
,
melanoma
,
type 2 diabetes mellitus
,
breast neoplasms
,
non-small-cell lung carcinoma
,
diabetes mellitus
,
lung neoplasms
,
rheumatoid arthritis
,
colorectal neoplasms
,
neoplasm metastasis
,
multiple myeloma
,
hepatitis
,
hepatitis c
,
carcinoma
,
liver neoplasms
,
hiv infections
,
hepatocellular carcinoma
,
transitional cell carcinoma
,
leukemia
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
myeloid leukemia chronic-phase
,
hepatitis b
,
chronic hepatitis b
,
chronic hepatitis
,
hepatitis a
,
hepacivirus
,
juvenile arthritis
,
esophageal neoplasms
,
wasting syndrome
,
cachexia
,
anorexia
,
urinary bladder neoplasms
,
rectal neoplasms
,
cardiovascular diseases
,
plasma cell neoplasms
,
lymphoid leukemia
,
acute coronary syndrome
,
syndrome
,
atrial fibrillation
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia accelerated phase
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
giant cell arteritis
,
glucose metabolism disorders
,
metabolic diseases
,
endocrine system diseases
,
body weight
,
exanthema
,
colonic neoplasms
,
hypertension
,
hyperglycemia
,
brain neoplasms
,
heart failure
,
bipolar disorder
,
sjogren's syndrome
,
prostatic neoplasms
,
hematologic neoplasms
,
primary myelofibrosis
Decellularized dermal allograft
tibial meniscus injuries
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use